Deep Dive: Here’s the case for buying Netflix’s stock now
After a brutal decline, Netflix's stock is cheap relative to earnings, and profit seems likely to grow.
: Medical debt declined during the pandemic, but that’s partly because many Americans delayed health care due to COVID-19
The drop was fueled by expanded Medicaid enrollments, temporary financial aid and people avoiding going to the doctor.
: ‘Anybody that’s middle class and below, we’re screwed’: Housing costs rise at the fastest pace in decades — but some Americans are already feeling the brunt
Housing costs have jumped by 5.1% in the past year, the fastest annual pace since 1991, while rents are up 4.8% from a year ago,...
Key Words: ‘Pay is the No. 1 reason people decide to take a job or leave a job’: Will record-high inflation push more people to go back to work?
The 5.5% increase in hourly wages over the past 12 months is not keeping up with 8.3% annual inflation.
: Musk’s ‘bizarre tweet’ is the latest reminder that retailer investors eyeing Twitter should proceed with caution
Musk’s ‘temporarily on hold’ tweet sent Twitter's trading volume over 65-day averages
The Moneyist: ‘We don’t have any children’: My family owns land that has been in our family for 100 years. I would like to leave this land to my wife. But what if she remarries?
‘My wife and I have started putting together a will. We have agreed to leave everything to each other.’
Deep Dive: Oil prices are surging — these eight stocks are still bargains for long-term investors
Many oil and gas companies are still trading cheaply to expected earnings. And low spending on new oil wells supports high energy prices for years...
In One Chart: Kathy Barnette’s late surge scrambles Republican Senate primary in battleground Pennsylvania
A surge by conservative commentator Kathy Barnette is scrambling Pennsylvania's Republican Senate primary just days before voters head to polls, shaking up one of this...
: Trulieve, Ascend Wellness CEOs chart multi-state growth
While earnings from Trulieve and Ascend Wellness contained some negative surprises, CEOs see richer returns ahead for 2022 amid multi-state rollouts.